Moderna, Inc. (MRNA) Insider Trading
Healthcare · Biological Products, (No Diagnostic Substances)
Open-market and disclosed Form 4 insider trading for Moderna, Inc. (MRNA) on InvestAtlant.
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-10-15 | Hoge Stephen | President | Sale | $8.64M |
| 2026-10-14 | Hoge Stephen | President | Sale | $96.4K |
| 2026-10-14 | Hoge Stephen | President | Sale | $8.28M |
| 2026-09-15 | Hoge Stephen | President | Sale | $5.88M |
| 2026-09-14 | Hoge Stephen | President | Sale | $5.81M |
| 2026-09-10 | Mock James M | Chief Financial Officer | Sale | $2.67M |
| 2026-09-10 | Mock James M | Chief Financial Officer | Sale | $2.02M |
| 2026-09-01 | Klinger Shannon Thyme | Chief Legal Officer | Sale | $485.8K |